The paradox of immune molecular recognition of α-galactosylceramide:: Low affinity, low specificity for CD1d, high affinity for αβ TCRs

被引:75
作者
Cantu, C
Benlagha, K
Savage, PB
Bendelac, A
Teyton, L
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[3] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84601 USA
关键词
D O I
10.4049/jimmunol.170.9.4673
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD1 resembles both class I and class II MHC but differs by the important aspect of presenting lipid/glycolipids, instead of peptides, to T cells. Biophysical studies of lipid/CD1 interactions have been limited, and kinetics of binding are in contradiction with functional studies. We have revisited this issue by designing new assays to examine the loading of CD1 with lipids. As expected for hydrophobic interactions, binding affinity was not high and had limited specificity. Lipid critical micelle concentration set the limitation to these studies. Once loaded onto CD1d, the recognition of glycolipids by alphabeta T cell receptor was studied by surface plasmon resonance using soluble Valpha14-Vbeta8.2 T cell receptors. The Valpha14 Jalpha18 chain could be paired with NK1.1 cell-derived Vbeta chain, or any Vbeta8 chain, to achieve high affinity recognition of alpha-galactosylceramide. Biophysical analysis indicated little effect of temperature or ionic strength on the binding interaction, in contrast to what has been seen in peptide/MHC-TCR studies. This suggests that there is less accommodation made by this TCR in recognizing alpha-galactosylceramide, and it can be assumed that the most rigid part of the Ag, the sugar moiety, is critical in the interaction.
引用
收藏
页码:4673 / 4682
页数:10
相关论文
共 47 条
  • [21] Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol
    Joyce, S
    Woods, AS
    Yewdell, JW
    Bennink, JR
    De Silva, AD
    Boesteanu, A
    Balk, SP
    Cotter, RJ
    Brutkiewicz, RR
    [J]. SCIENCE, 1998, 279 (5356) : 1541 - 1544
  • [22] CD1d-restricted and TCR-mediated activation of V(alpha)14 NKT cells by glycosylceramides
    Kawano, T
    Cui, JQ
    Koezuka, Y
    Toura, I
    Kaneko, Y
    Motoki, K
    Ueno, H
    Nakagawa, R
    Sato, H
    Kondo, E
    Koseki, H
    Taniguchi, M
    [J]. SCIENCE, 1997, 278 (5343) : 1626 - 1629
  • [23] BOTH A MONOCLONAL-ANTIBODY AND ANTISERA SPECIFIC FOR DETERMINANTS UNIQUE TO INDIVIDUAL CLONED HELPER T-CELL LINES CAN SUBSTITUTE FOR ANTIGEN AND ANTIGEN-PRESENTING CELLS IN THE ACTIVATION OF T-CELLS
    KAYE, J
    PORCELLI, S
    TITE, J
    JONES, B
    JANEWAY, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (03) : 836 - 856
  • [24] Hydrophobic ligand binding by Zn-α2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins
    Kennedy, MW
    Heikema, AP
    Cooper, A
    Bjorkman, PJ
    Sanchez, LM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) : 35008 - 35013
  • [25] IMMUNOPRECIPITATION OF CELL-SURFACE STRUCTURES OF CLONED CYTO-TOXIC LYMPHOCYTE-T BY CLONE-SPECIFIC ANTISERA
    KRANZ, DM
    SHERMAN, DH
    SITKOVSKY, MV
    PASTERNACK, MS
    EISEN, HN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (02): : 573 - 577
  • [26] LALONDE JM, 1994, J BIOL CHEM, V269, P25339
  • [27] AN INVARIANT T-CELL RECEPTOR-ALPHA CHAIN IS USED BY A UNIQUE SUBSET OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-SPECIFIC CD4+ AND CD4-8- T-CELLS IN MICE AND HUMANS
    LANTZ, O
    BENDELAC, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) : 1097 - 1106
  • [28] On the dynamics of TCR:CD3 complex cell surface expression and downmodulation
    Liu, HY
    Rhodes, M
    Wiest, DL
    Vignali, DAA
    [J]. IMMUNITY, 2000, 13 (05) : 665 - 675
  • [29] CD1d-glycolipid tetramers: A new tool to monitor natural killer T cells in health and disease
    MacDonald, HR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) : F15 - F19
  • [30] Development and selection of NKT cells
    MacDonald, HR
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (02) : 250 - 254